Table 3 GINA 2012- and 2018-defined control level at Week 12 in patients using ICS/LABA with and without LTRA
Baseline asthma severity | Control status at Week 12 | GINA 2012 | GINA 2018 | ||||
|---|---|---|---|---|---|---|---|
ICS/LABA + LTRA, n (%) | ICS/LABA, n (%) | Total, n (%) | ICS/LABA + LTRA, n (%) | ICS/LABA, n (%) | Total, n (%) | ||
Intermittent | Controlled | 32 (78.1) | 32 (80.0) | 64 (79.0) | 46 (86.8) | 47 (95.9) | 93 (91.2) |
Partly controlled | 9 (22.0) | 8 (20.0) | 17 (21.0) | 7 (13.2) | 2 (4.1) | 9 (8.8) | |
Uncontrolled | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
Total | 41 | 40 | 81 | 53 | 49 | 102 | |
Mild | Controlled | 122 (86.5) | 121 (85.8) | 243 (86.2) | 167 (86.1) | 178 (93.2) | 345 (89.6) |
Partly controlled | 18 (12.8) | 19 (13.5) | 37 (13.1) | 24 (12.4) | 11 (5.8) | 35 (9.1) | |
Uncontrolled | 1 (0.7) | 1 (0.7) | 2 (0.7) | 3 (1.6) | 2 (1.1) | 5 (1.3) | |
Total | 141 | 141 | 282 | 194 | 191 | 385 | |
Moderate | Controlled | 215 (78.5) | 149 (71.3) | 364 (75.4) | 325 (82.1) | 255 (85.3) | 580 (83.5) |
Partly controlled | 54 (19.7) | 58 (27.8) | 112 (23.2) | 61 (15.4) | 43 (14.4) | 104 (15.0) | |
Uncontrolled | 5 (1.8) | 2 (1.0) | 7 (1.5) | 10 (2.5) | 1 (0.3) | 11 (1.6) | |
Total | 274 | 209 | 483 | 396 | 299 | 695 | |
Severe | Controlled | 558 (59.6) | 338 (61.8) | 896 (60.4) | 921 (71.9) | 581 (77.6) | 1502 (74.0) |
Partly controlled | 339 (36.2) | 185 (33.8) | 524 (35.3) | 312 (24.4) | 150 (20.0) | 462 (22.8) | |
Uncontrolled | 40 (4.3) | 24 (4.4) | 64 (4.3) | 48 (3.8) | 18 (2.4) | 66 (3.3) | |
Total | 937 | 547 | 1484 | 1281 | 749 | 2030 | |